This cross-sectional study investigates the potential of novel tau radiotracer 18F-PI-2620 as a biomarker in patients with clinically diagnosed progressive supranuclear palsy.
from journals https://ift.tt/2C7izz3
from journals https://ift.tt/2C7izz3
Comments
Post a Comment